{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hyperhidrosis/background-information/causes/","result":{"pageContext":{"chapter":{"id":"5105b210-71a6-505f-9fe7-96123ea1beba","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field c61c3f65-5543-4044-8507-f0b45ef8ffe7 --><h2>What causes it?</h2><!-- end field c61c3f65-5543-4044-8507-f0b45ef8ffe7 -->","summary":"","htmlStringContent":"<!-- begin item 7bda977b-2b65-4e78-9825-bd53b5cbbf64 --><!-- begin field ef83a8f5-1193-47c5-98a0-665203b9fe01 --><p><strong>Generalized hyperhidrosis is usually secondary to an underlying cause, whereas focal hyperhidrosis is usually idiopathic. Less commonly, focal hyperhidrosis may also be secondary to a specific cause.</strong></p><ul><li><strong>Primary focal hyperhidrosis</strong><ul><li>The exact cause of primary focal hyperhidrosis is unknown, but a positive family history is reported in 30–50% of cases, suggesting a genetic association.</li><li>It is thought that excessive sympathetic activity of the autonomic nervous system affects the eccrine sweat glands, and it may be associated with environmental and emotional <a class=\"topic-reference internal-reference\" href=\"/topics/hyperhidrosis/diagnosis/assessment/\">triggers</a>.</li></ul></li><li><strong>Secondary generalized hyperhidrosis</strong><ul><li>Anxiety — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> for more information.</li><li>Physiological — pregnancy or menopause. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/menopause/\">Menopause</a> for more information.</li><li>Cardiovascular — such as heart failure or endocarditis. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a> for more information.</li><li>Infections — acute or chronic viral or bacterial infections such as tuberculosis, brucellosis, HIV, and malaria. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/malaria/\">Malaria</a> for more information.</li><li>Malignancy — Hodgkin's disease, myeloproliferative disorders. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/haematological-cancers-recognition-referral/\">Haematological cancers - recognition and referral</a> for more information.</li><li>Endocrine or metabolic — hyperthyroidism, diabetes mellitus (especially hypoglycaemia episodes), diabetes insipidus, phaeochromocytoma, acromegaly, carcinoid syndrome, hyperpituitarism, obesity, and gout. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a>, <a class=\"topic-reference external-reference\" href=\"/topics/obesity/\">Obesity</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/gout/\">Gout</a> for more information.</li><li>Neurological — such as Parkinson's disease, epilepsy, hypothalamic lesions. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/parkinsons-disease/\">Parkinson&#39;s disease</a> and <a class=\"topic-reference external-reference\" href=\"/topics/epilepsy/\">Epilepsy</a> for more information.</li><li>Drugs — such as cholinesterase inhibitors; antidepressants (venlafaxine, duloxetine, selective serotonin reuptake inhibitors, tricyclic antidepressants, trazodone, and mirtazapine); pilocarpine; propanolol, ciprofloxacin, aciclovir, esomeprazole, opioids.</li><li>Drug or alcohol misuse or withdrawal — such as cocaine and heroin. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/alcohol-problem-drinking/\">Alcohol - problem drinking</a> and <a class=\"topic-reference external-reference\" href=\"/topics/opioid-dependence/\">Opioid dependence</a> for more information.</li></ul></li><li><strong>Secondary focal hyperhidrosis (less common)</strong><ul><li>Neurological — such as stroke; peripheral neuropathy; diabetic autonomic neuropathy; reflex sympathetic dystrophy. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/stroke-tia/\">Stroke and TIA</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for more information.<ul><li>Diabetic neuropathy may also cause gustatory sweating (induced by salivation or chewing).</li><li>Spinal cord lesions and tumours may directly cause hyperhidrosis, or indirectly result in <a class=\"topic-reference internal-reference\" href=\"/topics/hyperhidrosis/management/management/#specialist-treatments\">compensatory hyperhidrosis</a>.</li><li>Reflex sympathetic dystrophy (complex regional pain syndrome) is a rare disorder of the sympathetic nervous system that is characterized by pain, swelling, and vasomotor dysfunction of an extremity.</li></ul></li><li>Intrathoracic — malignancy such as mesothelioma; cervical rib. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/\">Lung and pleural cancers - recognition and referral</a> for more information.<ul><li>Intrathoracic lesions may cause unilateral hyperhidrosis of the face, neck, and thorax due to compression of the sympathetic chain ganglion.</li></ul></li><li>Head and neck — gustatory sweating may be due to injury or surgery to the parotid gland (such as Frey's syndrome); invasion of the cervical sympathetic trunk by tumour; <em>Herpes zoster</em> of the preauricular area. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/shingles/\">Shingles</a> for more information.</li><li>Other — such as Raynaud's phenomenon; rheumatoid arthritis; cold injury. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/raynauds-phenomenon/\">Raynaud&#39;s phenomenon</a> and <a class=\"topic-reference external-reference\" href=\"/topics/rheumatoid-arthritis/\">Rheumatoid arthritis</a> for more information.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperhidrosis/references/\">Mahendiran, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperhidrosis/references/\">Hoorens and Ongenae, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperhidrosis/references/\">Benson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperhidrosis/references/\">Perera, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperhidrosis/references/\">Moraites, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyperhidrosis/references/\">Shalaby, 2015</a>]</p><!-- end field ef83a8f5-1193-47c5-98a0-665203b9fe01 --><!-- end item 7bda977b-2b65-4e78-9825-bd53b5cbbf64 -->","topic":{"id":"d2b54f08-d9cb-5147-a5aa-27e00b5cfd82","topicId":"9dacba69-b1b5-408f-a26d-a8e884033a25","topicName":"Hyperhidrosis","slug":"hyperhidrosis","lastRevised":"Last revised in May 2018","chapters":[{"id":"51b68ff2-e22f-5146-98b1-ed247449fada","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d247fa3c-c9d7-571f-9348-9d3a5b9a827f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3db15061-64ce-5067-8778-049202743014","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5d7852f4-9b06-5320-86de-ee56104314fc","slug":"changes","fullItemName":"Changes"},{"id":"37a4f575-9e64-5591-9459-613a50da6a5b","slug":"update","fullItemName":"Update"}]},{"id":"6608a015-2abe-5be8-882a-844689719b29","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2b31616d-6688-52e8-abfe-1c1e9567773c","slug":"goals","fullItemName":"Goals"},{"id":"164bcdd9-2d27-5afc-8857-f691d732e91a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f04b5274-abcd-5e07-9d0e-218d1b25b64a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35e097f0-6a28-54ce-91f0-09584dff79fd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0c245ac4-9908-5ec7-9443-c8d80afba273","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"479a66f8-4820-5838-babb-6b95327bf868","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e78f871f-1030-583b-b3a3-fd5932d63577","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f573ecee-b6e5-56a9-b610-ad80005d58b7","slug":"definition","fullItemName":"Definition"},{"id":"5105b210-71a6-505f-9fe7-96123ea1beba","slug":"causes","fullItemName":"Causes"},{"id":"3064f161-ea2d-5e49-9dbb-092faa5d5f71","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2e2ec09e-2d90-5f72-b368-813dea5aee6e","slug":"complications","fullItemName":"Complications"},{"id":"8132bf09-7bc9-55ce-8d34-d18405a2c171","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"13f16bec-4872-59e8-9996-2d88a053d081","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dfa50ec8-3fda-51b5-9903-61e58cc06753","slug":"assessment","fullItemName":"Assessment"}]},{"id":"45eb7b55-769c-50ef-9ce2-44c27469518c","fullItemName":"Management","slug":"management","subChapters":[{"id":"e0426c02-494d-544f-ac4b-5a344571652a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f83d14e6-24e3-513f-8d39-8b68803222b0","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"00e65205-feb9-59d3-8035-446868d1caab","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b7466396-123d-5050-8dd8-88ec7ce286f7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0574994c-afef-578e-ab8a-e3d78c0757e3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"68b43c06-7da3-5e66-ae57-bc294e301587","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"67e38cee-224f-54bd-ad61-431d5cc9c006","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"373675d4-86fc-5734-962f-d2aad8d56169","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"26f4cbb7-dfc9-5c02-9786-950141a26758","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e78f871f-1030-583b-b3a3-fd5932d63577","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}